In the esophageal squamous cell carcinoma (ESCC) [18, 19], hepatocellular carcinoma (HCC) [20–23] and bladder cancer [24, 25], there are contradictory descriptions regarding the role of HSP60 in cancer progression in different studies. This evidence concerns the gene HSPD1 and esophageal squamous cell carcinoma.